This federal contract award, valued at $30,126.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Ozempic, a 2 mg/dose (8 mg/3 ml) 3 ml medication, with a period of performance through November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award was not designated with a set-aside requirement, indicating open competition.
Generated 2/6/25, 9:15 AM